AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2019

Dec 28, 2019

30786_dirs_2019-12-27_a3169819-13eb-469c-bdb6-9e0417c6ac9a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-12-03

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-03	Bio-Rad B Common Stock	G	40	—	Acquired	279982	Direct
2019-12-03	Bio-Rad B Common Stock	G	40	—	Acquired	12811	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Bio-Rad A Common Stock	415182.00	Direct
Bio-Rad B Common Stock	4060054	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.